Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Class A Common Stock, $0.00001 par value per share
-
Shares outstanding
-
4,564,846
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
94,346,907
-
Shares change
-
+18,361,677
-
Total reported value, excl. options
-
$1,616,473,942
-
Value change
-
+$295,962,917
-
Put/Call ratio
-
63%
-
Number of buys
-
94
-
Number of sells
-
-19
-
Price
-
$17.13
Significant Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) as of Q4 2021
139 filings reported holding RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share as of Q4 2021.
RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94,346,907 shares
.
Largest 10 shareholders include BAILLIE GIFFORD & CO (22,123,155 shares), BlackRock Inc. (6,762,684 shares), VANGUARD GROUP INC (6,113,873 shares), Obvious Management Services, L.L.C. (5,977,631 shares), Data Collective IV GP, LLC (5,941,120 shares), STATE STREET CORP (4,656,727 shares), DCVC Opportunity Fund II GP, LLC (3,951,141 shares), Laurion Capital Management LP (3,923,713 shares), ALLIANCEBERNSTEIN L.P. (2,875,819 shares), and ARK Investment Management LLC (2,232,013 shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.